Back to results
US 11,781,143 B2Granted
Modulators of PNPLA3 expression
AssigneeIonis Pharmaceuticals, Inc.
InventorsSusan M. Freier, Huynh-Hoa Bui
Life of this patent
Estimating the term…
Abstract
The present embodiments provide methods, compounds, and compositions useful for inhibiting PNPLA3 expression, which may be useful for treating, preventing, or ameliorating a disease associated with PNPLA3.
Claims14
A compound comprising a modified oligonucleotide 16 to 30 linked nucleosides in length having a nucleobase sequence comprising the nucleobase sequence SEQ ID NO:
- 1089, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.